Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Am J Cardiol. 2010 Aug 11;106(7):946–951. doi: 10.1016/j.amjcard.2010.05.025

Table 5.

Relative Risk Models for 3 Year Events in Drug Eluting Versus Bare Metal Stent Patients

Event Unadjusted Hazard Ratio N (AHR model) Adjusted Hazard Ratio(AHR) 95% C.I. P- value
Death/myocardial infarction 0.78 394 0.72 0.49, 1.04 0.08
Target vessel revascularization 1.04 395 1.03 0.65, 1.62 0.91
Death/myocardial infarction/Target vessel revascularization 0.81 395 0.70 0.51, 0.95 0.02
Death/myocardial infarction/Target vessel revascularization excluding peri-procedural MI 0.97 395 0.82 0.62, 1.09 0.16